IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 216 filers reported holding IMMUNOGEN INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $32,457,356 | +107.9% | 2,045,202 | +147.2% | 2.05% | +100.1% |
Q2 2023 | $15,611,491 | +111.2% | 827,318 | -57.0% | 1.02% | +116.3% |
Q1 2023 | $7,390,203 | -11.6% | 1,924,532 | +14.1% | 0.47% | -4.6% |
Q4 2022 | $8,363,324 | +248.3% | 1,686,154 | +235.6% | 0.50% | +254.3% |
Q3 2022 | $2,401,000 | -53.2% | 502,393 | -56.0% | 0.14% | -67.3% |
Q2 2022 | $5,134,000 | -24.5% | 1,140,788 | -20.1% | 0.43% | -17.1% |
Q1 2022 | $6,798,000 | -47.6% | 1,428,169 | -18.4% | 0.52% | -31.9% |
Q4 2021 | $12,984,000 | +3098.0% | 1,749,882 | +1066.6% | 0.76% | +1843.6% |
Q1 2019 | $406,000 | -81.1% | 150,000 | -66.4% | 0.04% | -85.4% |
Q4 2018 | $2,146,000 | – | 447,075 | – | 0.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |